IBDEI22S ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34803,1,2,0)
 ;;=2^J1756
 ;;^UTILITY(U,$J,358.3,34803,1,3,0)
 ;;=3^IRON SUCROSE INJ 1MG
 ;;^UTILITY(U,$J,358.3,34804,0)
 ;;=J1745^^162^1771^57^^^^1
 ;;^UTILITY(U,$J,358.3,34804,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34804,1,2,0)
 ;;=2^J1745
 ;;^UTILITY(U,$J,358.3,34804,1,3,0)
 ;;=3^REMICADE 10MG
 ;;^UTILITY(U,$J,358.3,34805,0)
 ;;=J2916^^162^1771^15^^^^1
 ;;^UTILITY(U,$J,358.3,34805,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34805,1,2,0)
 ;;=2^J2916
 ;;^UTILITY(U,$J,358.3,34805,1,3,0)
 ;;=3^FERRIC GLUCOMATE 12.5MG
 ;;^UTILITY(U,$J,358.3,34806,0)
 ;;=J0129^^162^1771^1^^^^1
 ;;^UTILITY(U,$J,358.3,34806,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34806,1,2,0)
 ;;=2^J0129
 ;;^UTILITY(U,$J,358.3,34806,1,3,0)
 ;;=3^ABATACEPT INJ 10MG
 ;;^UTILITY(U,$J,358.3,34807,0)
 ;;=J1460^^162^1771^19^^^^1
 ;;^UTILITY(U,$J,358.3,34807,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34807,1,2,0)
 ;;=2^J1460
 ;;^UTILITY(U,$J,358.3,34807,1,3,0)
 ;;=3^GAMMA GLOBULIN INJ 1CC
 ;;^UTILITY(U,$J,358.3,34808,0)
 ;;=J1560^^162^1771^20^^^^1
 ;;^UTILITY(U,$J,358.3,34808,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34808,1,2,0)
 ;;=2^J1560
 ;;^UTILITY(U,$J,358.3,34808,1,3,0)
 ;;=3^GAMMA GLOBULIN INJ > 10CC
 ;;^UTILITY(U,$J,358.3,34809,0)
 ;;=J1561^^162^1771^21^^^^1
 ;;^UTILITY(U,$J,358.3,34809,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34809,1,2,0)
 ;;=2^J1561
 ;;^UTILITY(U,$J,358.3,34809,1,3,0)
 ;;=3^GAMUNEX 500MG
 ;;^UTILITY(U,$J,358.3,34810,0)
 ;;=J2353^^162^1771^46^^^^1
 ;;^UTILITY(U,$J,358.3,34810,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34810,1,2,0)
 ;;=2^J2353
 ;;^UTILITY(U,$J,358.3,34810,1,3,0)
 ;;=3^OCTREOTIDE INJ 1MG
 ;;^UTILITY(U,$J,358.3,34811,0)
 ;;=J1930^^162^1771^31^^^^1
 ;;^UTILITY(U,$J,358.3,34811,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34811,1,2,0)
 ;;=2^J1930
 ;;^UTILITY(U,$J,358.3,34811,1,3,0)
 ;;=3^LANREOTIDE INJ 1MG
 ;;^UTILITY(U,$J,358.3,34812,0)
 ;;=J0561^^162^1771^50^^^^1
 ;;^UTILITY(U,$J,358.3,34812,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34812,1,2,0)
 ;;=2^J0561
 ;;^UTILITY(U,$J,358.3,34812,1,3,0)
 ;;=3^PEN G BENZATHINE 100,000 UNITS
 ;;^UTILITY(U,$J,358.3,34813,0)
 ;;=J0558^^162^1771^51^^^^1
 ;;^UTILITY(U,$J,358.3,34813,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34813,1,2,0)
 ;;=2^J0558
 ;;^UTILITY(U,$J,358.3,34813,1,3,0)
 ;;=3^PEN G BENZATHINE/PROCAINE INJ 100,000 UNITS
 ;;^UTILITY(U,$J,358.3,34814,0)
 ;;=J2540^^162^1771^52^^^^1
 ;;^UTILITY(U,$J,358.3,34814,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34814,1,2,0)
 ;;=2^J2540
 ;;^UTILITY(U,$J,358.3,34814,1,3,0)
 ;;=3^PEN G POTASSIUM INJ 600,000 UNITS
 ;;^UTILITY(U,$J,358.3,34815,0)
 ;;=J2510^^162^1771^53^^^^1
 ;;^UTILITY(U,$J,358.3,34815,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34815,1,2,0)
 ;;=2^J2510
 ;;^UTILITY(U,$J,358.3,34815,1,3,0)
 ;;=3^PEN G PROCAINE INJ UP TO 600,000 UNITS
 ;;^UTILITY(U,$J,358.3,34816,0)
 ;;=J3370^^162^1771^63^^^^1
 ;;^UTILITY(U,$J,358.3,34816,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34816,1,2,0)
 ;;=2^J3370
 ;;^UTILITY(U,$J,358.3,34816,1,3,0)
 ;;=3^VANCOMYCIN HCI INJ 500MG
 ;;^UTILITY(U,$J,358.3,34817,0)
 ;;=J0696^^162^1771^9^^^^1
 ;;^UTILITY(U,$J,358.3,34817,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34817,1,2,0)
 ;;=2^J0696
 ;;^UTILITY(U,$J,358.3,34817,1,3,0)
 ;;=3^CEFTRIAXONE SODIUM INJ 250MG
 ;;^UTILITY(U,$J,358.3,34818,0)
 ;;=J0692^^162^1771^8^^^^1
 ;;^UTILITY(U,$J,358.3,34818,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,34818,1,2,0)
 ;;=2^J0692
 ;;^UTILITY(U,$J,358.3,34818,1,3,0)
 ;;=3^CEFEPIME HCL INJ 500MG
 ;;^UTILITY(U,$J,358.3,34819,0)
 ;;=J2185^^162^1771^37^^^^1
